Lion Point Capital, LP KINIKSA PHARMACEUTICALS LTD Transaction History
Lion Point Capital, LP
- $37.2 Million
- Q3 2024
Number of Shares
61,400
Previous 104,691
41.35%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%